Krystal Biotech, Inc. — Form 8-K
Filed July 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 2/100
What the filing says
Krystal Biotech filed an 8-K on July 21, 2026, disclosing Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). The filing contains only standard XBRL exhibits and an image file; no substantive business event, transaction, financial impact, counterparty details, dollar amounts, or operational changes are disclosed in the available text.
Why this rating
Filing is administrative disclosure with no material transaction, financial data, or operational event described. Routine periodic filing.
Extracted items
- 8.01 other event
- 9.01 exhibits
See more from July 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.